We also focused on the following group of markers to investigate the infiltration of various T cell subpopulations such as CD3+ , CD4+ , CD8+ , CD25+ , CD103+ , and CD39+ in the pancreatic cancer model with Ce6-PDT treatment (Fig. 5A–F). This evidence concerns the gene ENTPD1 and pancreatic neoplasm.